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Abstract
Recent studies have demonstrated that the endogenous cannabinoids are important modulators of
fertility in mammals. In particular, a role of the endocannabinoid system in early stages of embryo
development, oviductal transport of embryos, pregnancy maintenance and labour has been
demonstrated in rodents and/or in humans. In the present paper, we report the analysis of FAAH
activity and protein content in the mouse uterus as a function of the natural oestrus cycle stages.
Variations of FAAH activity are discussed in relationship to changes in sex steroid levels and to the
possible action of AEA on remodelling of uterine tissues.
Introduction
Recent studies have demonstrated that the endogenous
cannabinoids (bioactive fatty acid amides and esters
termed endocannabinoids) are important modulators of
fertility in mammals [1,2]. The endocannabinoid ananda-
mide (N-arachidonoylethanolamine, AEA) and conge-
ners, cannabinoid CB1 and CB2 receptors, the AEA-
synthesizing enzymes N-acetyltransferase (NAT) and N-
acylphosphatidylethanolamine (NAPE)-specific phos-
pholipase D, the AEA membrane transporter (AMT) and
the AEA-hydrolyzing enzyme fatty acid amide hydrolase
(FAAH), form the endocannabinoid system. A role of this
system in early stages of embryo development [2], oviduc-
tal transport of embryos [3], pregnancy maintenance and
labour [4,5], has been demonstrated in rodents and/or in
humans.
During early pregnancy, a proper endocannabinoid sig-
nalling in the uterus and in the preimplantation embryo
(both expressing CB1 receptor, AMT and FAAH), and pos-
sibly also in the circulating immune cells, appears to be
crucial for embryo development and implantation [2]. In
particular, high levels of AEA cause inhibition of trophob-
last proliferation at the interimplantation sites and induce
blastocyst apoptosis, while low levels of AEA at the
implantation sites favour trophoblast differentiation and
outgrowth [4,6-8]. In rodents, variation of AEA levels in
the pregnant uterus has been directly correlated with
FAAH expression and activity in uterine tissues [4,9,10].
Interestingly, FAAH activity and expression of at the
mRNA level can be modulated in the pregnant uterus by
the blastocyst itself, and by sex hormones [4,10,11].
Besides pregnant uterus and preimplantation embryo,
oviduct is also a target for endocannabinoid action. In
Published: 30 March 2006
Journal of Experimental & Clinical Assisted Reproduction2006, 3:3 doi:10.1186/1743-1050-3-3
Received: 28 November 2005
Accepted: 30 March 2006
This article is available from: http://www.jexpclinassistreprod.com/content/3/1/3
© 2006Klinger et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Experimental & Clinical Assisted Reproduction 2006, 3:3 http://www.jexpclinassistreprod.com/content/3/1/3
Page 2 of 4
(page number not for citation purposes)
fact, in the mouse CB1 deficiency causes early pregnancy
loss due to retention of embryos in the oviduct [3].
In the present paper, we report the analysis of FAAH activ-
ity and protein content in the mouse uterus as a function
of the natural oestrous cycle stages. Variations of FAAH
activity are discussed in relationship to changes in sex ster-
oid levels and to the possible action of AEA on remodel-
ling of uterine tissues.
Methods
Uterine tissue collection during the oestrous cycle
The 4–5 day oestrous cycle of mouse was monitored by
the examination of vaginal smears and classified in five
stages; proestrus, oestrus, early or late-metoestrus and
dioestrus [12]. CD-1 mice were killed by cervical disloca-
tion and uterus quickly removed in M2 without BSA [4],
cut in small pieces and rapidly frozen and stored at -70°C.
Assay of FAAH activity and protein content
The hydrolysis of 10 µM [3H] AEA (223 Ci/mmol, from
Perkin Elmer Life Sciences, Boston, MA) by the fatty acid
amide hydrolase (E.C. 3.5.1.4; FAAH) activity was assayed
in uterine extracts (20 µg/test)[4], by measuring the
release of [3H] arachidonic acid, at pH 9.0, by reversed
phase high performance liquid chromatography [4].
FAAH activity was expressed as pmol arachidonate
released per min per mg protein.
FAAH protein content was determined in uterine
homogenates (20 µg/test) by enzyme-linked immuno-
sorbent assay (ELISA), performed as reported [13]. For the
ELISA test rabbit anti-FAAH polyclonal antibodies [13]
were prepared by Primm S.r.l. (Milan, Italy) and were
used as first antibody (diluted 1:300), whereas goat anti-
rabbit alkaline phosphatase conjugates (Bio-Rad Labora-
tories, Hercules, CA) were used as second antibodies
(diluted 1:2000). Color development of the alkaline
phsphatase reaction was measured at 405 nm, using p-
nitrophenyl phosphate as substrate, and the ELISA test
was linear in the range 0–50 µg/well of homogenate [13].
Data reported in this paper are the means ± S.D. of at least
four independent experiments, each performed in dupli-
cate. Statistical analysis was performed by the nonpara-
metric Mann-Whitney U test, elaborating experimental
data by means of the InStat 4 program (GraphPAD Soft-
ware for Science, San Diego, CA).
Findings
The uterus undergoes cellular remodelling during each
sexual cycle, in order to be ready for a possible pregnancy.
In the absence of pregnancy, uterine changes are reversible
permitting preparation in a subsequent cycle. In the event
of mating and successful fertilization, however, the
changes in the uterus take another route to support preg-
nancy. The uterine cellular changes during cycle and preg-
nancy are regulated by the circulating levels of ovarian sex
steroids estradiol (E2) and progesterone (P).
The results of our analysis show that FAAH activity in the
mouse uterus changed as function of the oestrous cycle
stages, and that FAAH protein content paralleled the
enzyme activity (Fig. 1). In particular, the highest FAAH
activity and protein content were recorded at proestrus,
followed by a progressive decrease at oestrus and metoe-
strus; finally, dioestrus was characterized by the lowest
values for both parameters, down to ~20% or ~50% of the
proestrus values respectively (p < 0.01 for dioestrus versus
proestrus in both cases). In a variety of tissues high FAAH
hydrolyzing activity has been associated with low AEA lev-
els and viceversa, both in the central nervous system [14]
and in the periphery [15]. In particular, in a previous
study we have shown that uterine FAAH activity inversely
correlates with uterine AEA levels, so that higher FAAH
implicated lower AEA [11]. On this background, we can
speculate that the levels of AEA are very likely to be low at
proestrus, and that they progressively increase with a max-
imum at dioestrus.
Serum concentrations of estradiol (E2) and progesterone
(P) in the CD-1 mouse oestrous cycle have been carefully
analysed in previous studies [16,17]. It has been shown
that there are two peaks in both E2 and P endogenous
Fluctuations of uterine FAAH in the normal oestrous cycle of  mouse Figure 1
Fluctuations of uterine FAAH in the normal oestrous cycle of 
mouse. FAAH activity and protein content were measured as 
reported in "Materials and Methods", and were expressed as 
percentage of the proestrus value (100% = 250 ± 30 pmol/
min per mg protein, for the activity; 0.370 ± 0.030 absorb-
ance units at 405 nm, for the protein content). Vertical bars 
represent S.D. values. Pro, proestrus; Est, oestrus; EMet, 
early metoestrus; LMet, late metoestrus;Di, dioestrus.Journal of Experimental & Clinical Assisted Reproduction 2006, 3:3 http://www.jexpclinassistreprod.com/content/3/1/3
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concentrations. The highest E2 level occurs in proestrus,
followed by a smaller peak in late metoestrus. The serum
concentration of P exhibits a small peak in early oestrous
and a large broad peak that spans both metoestrus and
dioestrus. Following successful fertilization, both E2 and
P are required for uterine receptivity and implantation.
By overlapping the literature data on the endogenous lev-
els of E2 and P with the present analysis of FAAH, it
appears that the highest levels of E2 and the lowest levels
of P coincide with the highest FAAH activity (i.e., the low-
est local levels of AEA); instead, a low FAAH activity (i.e.,
a high local level of AEA) parallels decreasing and increas-
ing E2 and P concentrations, respectively. Altogether,
these data suggest that in the non-pregnant uterus endog-
enous E2 and P exert opposite effects on FAAH activity,
the first hormone being stimulatory and the second inhib-
itory. This seems at variance with the mouse pregnant
uterus, where treatment with exogenous E2 and P down-
modulates FAAH activity [4].
Among several effects that variation of FAAH activity and
the resulting different local AEA levels could exert on the
uterus, the action on the smooth muscle seems of particu-
lar interest. It has been demonstrated that endocannabi-
noids exert a potent and direct relaxant effect on human
pregnant myometrium [18] and coordinate oviductal
smooth muscle contraction during embryo transport [3].
Moreover, proliferation and apoptosis of uterine tissues
are also possible targets of endocannabinoid action [19-
22]. In fact, the pro-apoptotic activity of AEA has been
documented in several cells and tissues [21], including
mouse blastocyst [2]. It is well established that one of
basic events of uterine cellular changes is the systemic cell
turnover, that consists of cell renewal by proliferation and
cell death by apoptosis. While uterine epithelial prolifera-
tive indices are highest on the proestrus day, epithelial
apoptotic indices are lowest on the same day. A reverse
pattern was demonstrated between uterine cell prolifera-
tion and apoptosis on the oestrous day [23-25]. The
increased uterine cell proliferation has been correlated
with increasing ovarian E2 secretion on the proestrus day
[26], while increased uterine epithelial apoptosis on the
oestrous day has been attributed to decline in serum E2
levels [27]. In addition, a number of studies in humans
also showed that preovulatory ovarian estrogen secretion
stimulates proliferation of uterine glandular epithelial
cells, especially in functional endometrium, during prolif-
erative phase. A rapid increase in the apoptotic index was
noted in both epithelium and stroma during the last days
of the cycle (late secretory phase), with a maximum index
on the second day of menstruation [28]. On the basis of
our study, it is possible to speculate that at proestrus low
levels of AEA could favour the proliferation of uterine tis-
sues, while at metaestrus-dioestrus high levels of AEA con-
tribute to programmed cell death.
In conclusion, we report here the analysis of FAAH activity
and protein content in the mouse uterus, showing varia-
tions as a function of the oestrous cycle stages which can
be related to changes of sex steroid levels and tissue
remodelling. The present data may form the basis for fur-
ther studies on the action of endocannabinoid signalling
in this organ, and on its impact on reproductive physiol-
ogy.
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